Trends in incidence, molecular diagnostics, and treatment of patients with breast cancer in Kazakhstan, 2014-2019

O. Shatkovskaya1, D. Kaidarova1, Z. Dushimova1, M. Sagi1, R. Abdrakhmanov1

1. JSC “Kazakh Institute of Oncology and Radiology”, Almaty, the Republic of Kazakhstan

DOI: 10.52532/2521-6414-2021-4-62-16-23

УДК: 618.19-006.6-033.2+577.2:615.277.3

Год: 2021 выпуск: 62 номер: 4 страницы: 16-23

Скачать PDF: 2012.2-3.24-25_10.pdf

Ключевые слова: breast cancer incidence, HR-positive HER2-negative metastatic breast cancer (HR+/HER2-mBC), endocrine therapy (ET), CDK4/6 inhibitor, palbociclib.

Ссылка: O. Shatkovskaya, D. Kaidarova, Z. Dushimova, M. Sagi, R. Abdrakhmanov. Trends in incidence, molecular diagnostics, and treatment of patients with breast cancer in Kazakhstan, 2014-2019.. Онкология и радиология Казахстана, 2021, 62 (4), 16-23.

[contact-form-7 404 "Not Found"]